These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33241024)

  • 1. Overexpression of DJ-1 alleviates autosomal dominant polycystic kidney disease by regulating cell proliferation, apoptosis, and mitochondrial metabolism
    Li Z; Zhou J; Li Y; Yang F; Lian X; Liu W
    Ann Transl Med; 2020 Sep; 8(18):1175. PubMed ID: 33241024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl-CoA thioesterase 13 (
    Wang B; Yang Q; Che L; Sun L; Du N
    Aging (Albany NY); 2024 Aug; 16(16):11877-11892. PubMed ID: 39172111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway.
    Xu T; Wang NS; Fu LL; Ye CY; Yu SQ; Mei CL
    Mol Biol Rep; 2012 Jul; 39(7):7743-53. PubMed ID: 22415852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
    Lanoix J; D'Agati V; Szabolcs M; Trudel M
    Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
    Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
    PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.
    Lee EJ; Park EY; Mun H; Chang E; Ko JY; Kim DY; Park JH
    FASEB J; 2015 Aug; 29(8):3506-14. PubMed ID: 25934702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
    Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
    Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
    Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mitochondrial Ca
    Yanda MK; Tomar V; Cole R; Guggino WB; Cebotaru L
    Cell Calcium; 2022 Jan; 101():102501. PubMed ID: 34823104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease.
    Chea SW; Lee KB
    Yonsei Med J; 2009 Feb; 50(1):105-11. PubMed ID: 19259356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ouabain enhances renal cyst growth in a slowly progressive mouse model of autosomal dominant polycystic kidney disease.
    Trant J; Sanchez G; McDermott JP; Blanco G
    Am J Physiol Renal Physiol; 2023 Dec; 325(6):F857-F869. PubMed ID: 37823195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
    Cordido A; Nuñez-Gonzalez L; Martinez-Moreno JM; Lamas-Gonzalez O; Rodriguez-Osorio L; Perez-Gomez MV; Martin-Sanchez D; Outeda P; Chiaravalli M; Watnick T; Boletta A; Diaz C; Carracedo A; Sanz AB; Ortiz A; Garcia-Gonzalez MA
    J Am Soc Nephrol; 2021 Aug; 32(8):1913-1932. PubMed ID: 34155062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
    Kurbegovic A; Trudel M
    Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obacunone Retards Renal Cyst Development in Autosomal Dominant Polycystic Kidney Disease by Activating NRF2.
    Qiu Z; He J; Shao G; Hu J; Li X; Zhou H; Li M; Yang B
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.
    Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Sioulis A; Balaskas E; Zebekakis P; Sarafidis PA
    Kidney Blood Press Res; 2018; 43(3):744-754. PubMed ID: 29794429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells.
    de Stephanis L; Mangolini A; Servello M; Harris PC; Dell'Atti L; Pinton P; Aguiari G
    J Cell Physiol; 2018 Sep; 233(9):6911-6924. PubMed ID: 29323708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Indanone retards cyst development in ADPKD mouse model by stabilizing tubulin and down-regulating anterograde transport of cilia.
    Li XW; Ran JH; Zhou H; He JZ; Qiu ZW; Wang SY; Wu MN; Zhu S; An YP; Ma A; Li M; Quan YZ; Li NN; Ren CQ; Yang BX
    Acta Pharmacol Sin; 2023 Feb; 44(2):406-420. PubMed ID: 35906293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.
    Buchholz B; Klanke B; Schley G; Bollag G; Tsai J; Kroening S; Yoshihara D; Wallace DP; Kraenzlin B; Gretz N; Hirth P; Eckardt KU; Bernhardt WM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3458-65. PubMed ID: 21804086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.